Effects of Low-Dose Testosterone Undecanoate Treatment on Bone Mineral Density and Bone Turnover Markers in Elderly Male Osteoporosis with Low Serum Testosterone
This prospective 2-year, single-center, randomized, placebo-controlled, open-label clinical trial was performed to evaluate the efficacy of low-dose testosterone undecanoate (TU) treatment on bone mineral density (BMD) and biochemical markers of bone turnover in elderly male osteoporosis with low se...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2013/570413 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832557060129030144 |
|---|---|
| author | Yan-Jiao Wang Jun-Kun Zhan Wu Huang Yi Wang Yuan Liu Sha Wang Pan Tan Zhi-Yong Tang You-Shuo Liu |
| author_facet | Yan-Jiao Wang Jun-Kun Zhan Wu Huang Yi Wang Yuan Liu Sha Wang Pan Tan Zhi-Yong Tang You-Shuo Liu |
| author_sort | Yan-Jiao Wang |
| collection | DOAJ |
| description | This prospective 2-year, single-center, randomized, placebo-controlled, open-label clinical trial was performed to evaluate the efficacy of low-dose testosterone undecanoate (TU) treatment on bone mineral density (BMD) and biochemical markers of bone turnover in elderly male osteoporosis with low serum testosterone. A total of 186 elderly male osteoporosis patients with low serum testosterone were randomized into three groups: low-dose TU (20 mg, per day), standard-dose TU (40 mg, per day), and placebo group with a 24-month followup. Since the 6th month in standard-dose TU group or since the 12th month followup in low-dose TU group and throughout the study, lumbar spine and femoral neck BMD and serum levels of free testosterone, estradiol, and bone alkaline phosphatase significantly increased. There were no significant differences between groups of low-dose TU and standard dose TU in the percentage of changes of these data since the 18th month followup and throughout the study. No side effects on prostate glands including prostate specific antigen were found. In conclusion, low-dose TU (20 mg, per day) may be a cost effective and safe protocol for treating elderly male osteoporosis with low serum testosterone. |
| format | Article |
| id | doaj-art-d5508a6cca754bcca83edf859497fac6 |
| institution | Kabale University |
| issn | 1687-8337 1687-8345 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Endocrinology |
| spelling | doaj-art-d5508a6cca754bcca83edf859497fac62025-02-03T05:43:51ZengWileyInternational Journal of Endocrinology1687-83371687-83452013-01-01201310.1155/2013/570413570413Effects of Low-Dose Testosterone Undecanoate Treatment on Bone Mineral Density and Bone Turnover Markers in Elderly Male Osteoporosis with Low Serum TestosteroneYan-Jiao Wang0Jun-Kun Zhan1Wu Huang2Yi Wang3Yuan Liu4Sha Wang5Pan Tan6Zhi-Yong Tang7You-Shuo Liu8Geriatric Department of the Second Xiang-Ya Hospital, Institute of Aging and Geriatric Research, Central South University, No. 139 Middle Renmin Road, Changsha, Hunan 410011, ChinaGeriatric Department of the Second Xiang-Ya Hospital, Institute of Aging and Geriatric Research, Central South University, No. 139 Middle Renmin Road, Changsha, Hunan 410011, ChinaGeriatric Department of the Second Xiang-Ya Hospital, Institute of Aging and Geriatric Research, Central South University, No. 139 Middle Renmin Road, Changsha, Hunan 410011, ChinaGeriatric Department of the Second Xiang-Ya Hospital, Institute of Aging and Geriatric Research, Central South University, No. 139 Middle Renmin Road, Changsha, Hunan 410011, ChinaGeriatric Department of the Second Xiang-Ya Hospital, Institute of Aging and Geriatric Research, Central South University, No. 139 Middle Renmin Road, Changsha, Hunan 410011, ChinaGeriatric Department of the Second Xiang-Ya Hospital, Institute of Aging and Geriatric Research, Central South University, No. 139 Middle Renmin Road, Changsha, Hunan 410011, ChinaGeriatric Department of the Second Xiang-Ya Hospital, Institute of Aging and Geriatric Research, Central South University, No. 139 Middle Renmin Road, Changsha, Hunan 410011, ChinaGeriatric Department of the Second Xiang-Ya Hospital, Institute of Aging and Geriatric Research, Central South University, No. 139 Middle Renmin Road, Changsha, Hunan 410011, ChinaGeriatric Department of the Second Xiang-Ya Hospital, Institute of Aging and Geriatric Research, Central South University, No. 139 Middle Renmin Road, Changsha, Hunan 410011, ChinaThis prospective 2-year, single-center, randomized, placebo-controlled, open-label clinical trial was performed to evaluate the efficacy of low-dose testosterone undecanoate (TU) treatment on bone mineral density (BMD) and biochemical markers of bone turnover in elderly male osteoporosis with low serum testosterone. A total of 186 elderly male osteoporosis patients with low serum testosterone were randomized into three groups: low-dose TU (20 mg, per day), standard-dose TU (40 mg, per day), and placebo group with a 24-month followup. Since the 6th month in standard-dose TU group or since the 12th month followup in low-dose TU group and throughout the study, lumbar spine and femoral neck BMD and serum levels of free testosterone, estradiol, and bone alkaline phosphatase significantly increased. There were no significant differences between groups of low-dose TU and standard dose TU in the percentage of changes of these data since the 18th month followup and throughout the study. No side effects on prostate glands including prostate specific antigen were found. In conclusion, low-dose TU (20 mg, per day) may be a cost effective and safe protocol for treating elderly male osteoporosis with low serum testosterone.http://dx.doi.org/10.1155/2013/570413 |
| spellingShingle | Yan-Jiao Wang Jun-Kun Zhan Wu Huang Yi Wang Yuan Liu Sha Wang Pan Tan Zhi-Yong Tang You-Shuo Liu Effects of Low-Dose Testosterone Undecanoate Treatment on Bone Mineral Density and Bone Turnover Markers in Elderly Male Osteoporosis with Low Serum Testosterone International Journal of Endocrinology |
| title | Effects of Low-Dose Testosterone Undecanoate Treatment on Bone Mineral Density and Bone Turnover Markers in Elderly Male Osteoporosis with Low Serum Testosterone |
| title_full | Effects of Low-Dose Testosterone Undecanoate Treatment on Bone Mineral Density and Bone Turnover Markers in Elderly Male Osteoporosis with Low Serum Testosterone |
| title_fullStr | Effects of Low-Dose Testosterone Undecanoate Treatment on Bone Mineral Density and Bone Turnover Markers in Elderly Male Osteoporosis with Low Serum Testosterone |
| title_full_unstemmed | Effects of Low-Dose Testosterone Undecanoate Treatment on Bone Mineral Density and Bone Turnover Markers in Elderly Male Osteoporosis with Low Serum Testosterone |
| title_short | Effects of Low-Dose Testosterone Undecanoate Treatment on Bone Mineral Density and Bone Turnover Markers in Elderly Male Osteoporosis with Low Serum Testosterone |
| title_sort | effects of low dose testosterone undecanoate treatment on bone mineral density and bone turnover markers in elderly male osteoporosis with low serum testosterone |
| url | http://dx.doi.org/10.1155/2013/570413 |
| work_keys_str_mv | AT yanjiaowang effectsoflowdosetestosteroneundecanoatetreatmentonbonemineraldensityandboneturnovermarkersinelderlymaleosteoporosiswithlowserumtestosterone AT junkunzhan effectsoflowdosetestosteroneundecanoatetreatmentonbonemineraldensityandboneturnovermarkersinelderlymaleosteoporosiswithlowserumtestosterone AT wuhuang effectsoflowdosetestosteroneundecanoatetreatmentonbonemineraldensityandboneturnovermarkersinelderlymaleosteoporosiswithlowserumtestosterone AT yiwang effectsoflowdosetestosteroneundecanoatetreatmentonbonemineraldensityandboneturnovermarkersinelderlymaleosteoporosiswithlowserumtestosterone AT yuanliu effectsoflowdosetestosteroneundecanoatetreatmentonbonemineraldensityandboneturnovermarkersinelderlymaleosteoporosiswithlowserumtestosterone AT shawang effectsoflowdosetestosteroneundecanoatetreatmentonbonemineraldensityandboneturnovermarkersinelderlymaleosteoporosiswithlowserumtestosterone AT pantan effectsoflowdosetestosteroneundecanoatetreatmentonbonemineraldensityandboneturnovermarkersinelderlymaleosteoporosiswithlowserumtestosterone AT zhiyongtang effectsoflowdosetestosteroneundecanoatetreatmentonbonemineraldensityandboneturnovermarkersinelderlymaleosteoporosiswithlowserumtestosterone AT youshuoliu effectsoflowdosetestosteroneundecanoatetreatmentonbonemineraldensityandboneturnovermarkersinelderlymaleosteoporosiswithlowserumtestosterone |